Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 52026 | AMG-319 | 1608125-21-8 | 98% |  |
| AMG 319 is an investigational, highly selective, small molecule inhibitor of PI3K tha | ||||
| 71805 | Capivasertib ( AZD5363 ) | 1143532-39-1 | 98% | _1143532-39-1.png) |
| Capivasertib is a novel pyrrolopyrimidine derivative, and an orally available inhibit | ||||
| 90731 | GDC-0810 ( Brilanestrant , ARN-810 ) | 1365888-06-7 | ≧98.0% | _1365888-06-7.png) |
| GDC-0810 (Brilanestrant, ARN-810, RG6046) is a selective estrogen receptor degrader ( | ||||
| 92802 | SAG | 912545-86-9 | 99.03% |  |
| SAG is a potent Smoothened (Smo) receptor agonist (Kd = 59 nM); antagonizes Cyclopami | ||||
| 102703 | AZD-8835 | 1620576-64-8 | ≧98.0% |  |
| AZD8835 is a potent and selective inhibitor of PI3Kalpha and PI3Kdelata with excellen | ||||
| 111013 | MGCD-265-analog | 875337-44-3 | ≧98.0% |  |
| MGCD-265-analog is a tyrosine kinase inhibitor that selectively targets MET and Axl.M | ||||
| 112101 | AV-412 | 451492-95-8 | 99.38% |  |
| AV-412 is an EGFR/HER2 inhibitor that binds to and inhibits the epidermal growth fact | ||||
| 120103 | AGI-5198 | 1355326-35-0 | 98% |  |
| AGI-5198 is a novel R132H-IDH1 inhibitor, identified through a high-throughput screen | ||||
| 122203 | Dalcetrapib | 211513-37-0 | 98% |  |
| Dalcetrapib is a rhCETP inhibitor with IC50 of 0.2 M that increases the plasma HDL ch | ||||
| 122518 | SB-742457 ( Intepirdine ) | 607742-69-8 | 98% | _607742-69-8.png) |
| SB-742457(Intepirdine) is a highly selective 5-HT6 receptor antagonist with pKi of 9. | ||||
| 122524 | GW2580 | 870483-87-7 | 98% |  |
| GW2580 is an orally bioavailable inhibitor of c-FMS kinase; completely inhibited huma | ||||
| 122805 | Balipodect ( TAK-063 ) | 1238697-26-1 | 98% | _1238697-26-1.png) |
| Balipodect (TAK 063 ) is a novel PDE10A inhibitor. It has shown high inhibitory activ | ||||